The ESMO met with Dr Maria De Santis of the Kaiser Franz Josef Hospital, Vienna, Austria to discuss on how genetics is important in genitourinary cancers and about plethora of novel targeted therapies. In this short interview, she digs into current and future treatment outlook. Read more
here.
No comments:
Post a Comment